RAS polymorphisms in cancerous and benign breast tissue

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 2, 2011, Pages 85-92

  Mendizábal Ruiz, Adriana P ^a   Morales, José ^a   Castro Martinez, Xochitl ^a,b   Gutierrez Rubio, Susan A ^a   Valdez, Laura ^c   Vásquez Camacho, José G ^d,e   Sanchez Corona, José ^d,f   Moran Moguel, Maria C ^f  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b Centro Universitario de Ciencias de la Salud   (Mexico)

^c UNIVERSIDAD DE COLIMA   (Mexico)

^d INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^e HOSPITAL DE ESPECIALIDADES   (Mexico)

^f CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

Author keywords

ACE gene; AGT gene; AGT1R gene; benign breast disease; breast cancer; polymorphisms; REN gene; renin angiotensin system

Indexed keywords

ANGIOTENSIN 2 RECEPTOR SUBTYPE 1; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER RISK; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGE DISTRIBUTION; AGED; ALLELES; BREAST; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM;

EID: 79958069411     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320310383735     Document Type: Article

References (51)

1. Frossard PM, Malloy MJ, Lestringant GG and Kane JP Haplotypes of the human renin gene associated with essential hypertension and stroke. J Hum Hypertens 2001 ; 151: 49-55. (Pubitemid 32106768)
2. Fujita M., Hayashi I., Yamashina S., Itoman M. and Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002 ; 294: 441-447. (Pubitemid 34694114)
3. Greco S., Muscella A., Elia MG, et al. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. J Cell Physiol 2003 ; 196: 370-377. (Pubitemid 36775885)
4. Deshayes F. and Nahmias C. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 2005 ; 16: 293-299. (Pubitemid 41206635)
5. Yaren A., Turgut S., Kursunluoglu R., et al. Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients. Tohoku J Exp Med 2006 ; 210: 109-116. (Pubitemid 44575585)
6. Ebert MP, Lendeckel U., Westphal S., et al. The angiotensin I-converting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer. Cancer Epidemiol Biomarkers Prev 2005 ; 14: 2987-2989. (Pubitemid 43068835)
7. Rocken C., Rohl FW, Diebler E., et al. The angiotensin II/ angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev 2007 ; 16: 1206-1212. (Pubitemid 46984960)
8. Freitas-Silva M., Pereira D., Coelho C., Bicho M., Lopes C. and Medeiros R. Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet 2004 ; 155: 42-46. (Pubitemid 39446611)
9. Medeiros R., Vasconcelos A., Costa S., et al. Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 2004 ; 202: 330-335. (Pubitemid 38325242)
10. Koh WP, Yuan JM, Sun CL, et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003 ; 63: 573-578.
11. Gonzalez-Zuloeta Ladd AM, Vasquez AA, Sayed-Tabatabaei FA, et al. Angiotensin-converting enzyme gene insertion/ deletion polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005 ; 14: 2143-2146. (Pubitemid 41603259)
12. Haiman CA, Henderson SO, Bretsky P., Kolonel LN and Henderson BE Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 2003 ; 63: 6984-6987. (Pubitemid 37322985)
13. Alves Correa SA, Ribeiro de Noronha SM, Nogueira-de-Souza NC, et al. Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J Renin Angiotensin Aldosterone Syst 2009 ; 10: 51-58.
14. Koh WP, Yuan JM, Van Den Berg D., Lee HP and Yu MC Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005 ; 26: 459-464. (Pubitemid 40246568)
15. Gonzalez-Zuloeta Ladd AM, Arias Vasquez A., Siemes C., et al. Differential roles of Angiotensinogen and Angiotensin Receptor type 1 polymorphisms in breast cancer risk. Breast Cancer Res Treat 2007 ; 101: 299-304.
16. Miller JA and Scholey JW The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr Opin Nephrol Hypertens 2004 ; 13: 101-106. (Pubitemid 39069905)
17. Danser AH and Schunkert H. Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases. Eur J Pharmacol 2000 ; 410: 303-316. (Pubitemid 32008152)
18. Naftilan AJ, Williams R., Burt D., et al. A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension. Hypertension 1989 ; 14: 614-618. (Pubitemid 20020821)
19. Soubrier F., Jeunemaitre X., Rigat B., Houot AM, Cambien F. and Corvol P. Similar frequencies of renin gene restriction fragment length polymorphisms in hypertensive and normotensive subjects. Hypertension 1990 ; 16: 712-717.
20. Frossard PM, Lestringant GG, Elshahat YI, John A. and Obineche EN An MboI two-allele polymorphism may implicate the human renin gene in primary hypertension. Hypertens Res 1998 ; 21: 221-225.
21. Barley J., Carter ND, Cruickshank JK, et al. Renin and atrial natriuretic peptide restriction fragment length polymorphisms: association with ethnicity and blood pressure. J Hypertens 1991 ; 9: 993-996.
22. Frossard PM, Lestringant GG, Malloy MJ and Kane JP Human renin gene BglI dimorphism associated with hypertension in two independent populations. Clin Genet 1999 ; 56: 428-433. (Pubitemid 30042688)
23. Deinum J., Tarnow L., van Gool JM, et al. Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy. Nephrol Dial Transplant 1999 ; 14: 1904-1911. (Pubitemid 29358886)
24. Lalouel JM, Rohrwasser A., Terreros D., Morgan T. and Ward K. Angiotensinogen in essential hypertension: from genetics to nephrology. J Am Soc Nephrol 2001 ; 12: 606-615. (Pubitemid 32180032)
25. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P. and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990 ; 86: 1343-1346. (Pubitemid 20370444)
26. Soubrier F., Martin S., Alonso A., et al. High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur J Hum Genet 2002 ; 10: 553-561. (Pubitemid 35012310)
27. Foy CA, Rice GI, Ossei-Gerning N., Mansfield MW and Grant PJ Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography. Hum Genet 1997 ; 100: 420-425. (Pubitemid 27386851)
28. Zhu X., Bouzekri N., Southam L., et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001 ; 68: 1139-1148. (Pubitemid 32424413)
29. Bonnardeaux A., Davies E., Jeunemaitre X., et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994 ; 24: 63-69. (Pubitemid 24195405)
30. Kainulainen K., Perola M., Terwilliger J., et al. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 1999 ; 33: 844-849. (Pubitemid 29140444)
31. Tavassoli FA and Devilee P., World Health Organization, International Agency for Research on Cancer. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC ; 2003.
32. Valdez-Velazquez LL, Quintero-Ramos A., Perez SA, et al. Genetic polymorphisms of the renin-angiotensin system in preterm delivery and premature rupture of membranes. J Renin Angiotensin Aldosterone Syst 2007 ; 8: 160-168. (Pubitemid 351166261)
33. Russ AP, Maerz W., Ruzicka V., Stein U. and Gross W. Rapid detection of the hypertension-associated Met235→Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993 ; 2: 609-610. (Pubitemid 23140035)
34. Keavney B., McKenzie CA, Connell JM, et al. Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 1998 ; 7: 1745-1751. (Pubitemid 28464149)
35. Berge KE, Bakken A., Bohn M., Erikssen J. and Berg K. A DNA polymorphism at the angiotensin II type 1 receptor (AT1R) locus and myocardial infarction. Clin Genet 1997 ; 52: 71-76. (Pubitemid 27344785)
36. Raymond M., Rousset F. Genepop (version-1.2) - population-genetics software for exact tests and ecumenicism. J Hered 1995 ; 86: 248-249.
37. Jeunemaitre X., Rigat B., Charru A., Houot AM, Soubrier F. and Corvol P. Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 1992 ; 88: 301-306.
38. Nguyen G., Burckle C. and Sraer JD The renin receptor: the facts, the promise and the hope. Curr Opin Nephrol Hypertens 2003 ; 12: 51-55. (Pubitemid 36092315)
39. Huang Y., Noble NA, Zhang J., Xu C. and Border WA Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int 2007 ; 72: 45-52. (Pubitemid 47014443)
40. Escobar E., Rodriguez-Reyna TS, Arrieta O. and Sotelo J. Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol 2004 ; 2: 385-399. (Pubitemid 39200189)
41. Corvol P., Lamande N., Cruz A., Celerier J. and Gasc JM Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen. Curr Hypertens Rep 2003 ; 5: 149-154. (Pubitemid 38898945)
42. Schneider BP and Miller KD Angiogenesis of breast cancer. J Clin Oncol 2005 ; 23: 1782-1790. (Pubitemid 46211430)
43. Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998 ; 352: 179-184. (Pubitemid 28327802)
44. Yoshiji H., Kuriyama S., Noguchi R. and Fukui H. Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy. Curr Cancer Drug Targets 2004 ; 4: 555-567. (Pubitemid 39536376)
45. Rosenthal T. and Gavras I. Angiotensin inhibition and malignancies: a review. J Hum Hypertens 2009 ; 23: 623-635.
46. Ignjacev-Lazich I., Kintsurashvili E., Johns C., et al. Angiotensin-converting enzyme regulates bradykinin receptor gene expression. Am J Physiol Heart Circ Physiol 2005 ; 289: H1814-1820.
47. Thekkumkara TJ, Thomas WG, Motel TJ and Baker KM Functional role for the angiotensin II receptor (AT1A) 3′-untranslated region in determining cellular responses to agonist: evidence for recognition by RNA binding proteins. Biochem J 1998 ; 329: 255-264.
48. Thekkumkara TJ and Linas SL Evidence for involvement of 3′-untranslated region in determining angiotensin II receptor coupling specificity to G-protein. Biochem J 2003 ; 370: 631-639. (Pubitemid 36315151)
49. Tahmasebi M., Barker S., Puddefoot JR and Vinson GP Localisation of renin-angiotensin system (RAS) components in breast. Br J Cancer 2006 ; 95: 67-74. (Pubitemid 43980556)
50. Tahmasebi M., Puddefoot JR, Inwang ER, Goode AW, Carpenter R. and Vinson GP Transcription of the prorenin gene in normal and diseased breast. Eur J Cancer 1998 ; 34: 1777-1782. (Pubitemid 28474235)
51. De Paepe B., Verstraeten VL, De Potter CR, Vakaet LA and Bullock GR Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma. Histochem Cell Biol 2001 ; 116: 247-254. (Pubitemid 32930137)